LETTER TO THE EDITOR |
To the Editor.
We read with great interest the article by Williams et al,1 which revealed a very high prevalence (7%) of impaired fasting glucose (IFG) among US adolescents (data were from the 19992000 National Health and Nutrition Examination Survey). Moreover, patients with IFG had features of insulin resistance and cardiovascular risk factors. Among overweight subjects, the prevalence of IFG raised to 17.8%.
Quite surprisingly, our experience with obese adolescents is very different.
We examined 450 obese adolescents (245 girls) from southern Italy. Their mean BMI z score2 was 3.8 ± 1.6 (range: 28). Their mean age was 14.1 ± 1.6 years (range: 1219 years). The prevalence of IFG was only 1.5% (4 girls and 3 boys). Moreover, in the 126 patients who underwent an oral glucose-tolerance test, the prevalence of impaired glucose tolerance (IGT) was 5% (4 girls and 3 boys). One patient with IGT had IFG.
Some observations arise from these data. In adolescents from southern Italy the prevalence of IFG is much lower than in American adolescents; this difference could be a result of dietary habits and/or a particular genetic background. This latter hypothesis has probably only a secondary role, because also among the non-Hispanic white American adolescents1 the prevalence of IFG remains very high (7%).
The American Diabetes Association identified people with prediabetes, defined as IGT or IFG, as a high-risk group for the development of diabetes.3 Therefore, although the prevalence of obesity in southern Europe,4 as in the United States, is increasing alarmingly, in the future decades the occurrence of type 2 diabetes and related cardiovascular risk factors will be probably lower among southern European adolescents.
It could be useful to recognize any protective factors that prevent obese Mediterranean adolescents from developing prediabetes.
FOOTNOTES
Statements appearing here are those of the writers and do not represent the offcial position of the American Academy of Pediatrics or its Committees. Comments on any topic, including the contents of PEDIATRICS, are invited from all members of the profession; those accepted for publication will not be subject to major editorial revision but generally must be no more than 400 words in length. The editors reserve the right to publish replies and may solicit responses from authors and others.
Please see www.pediatrics.org for instructions on submitting letters.
REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||